CompletedNo phase
Relinking Diagnosed But Untreated HCV Patients Back Into Care.
Key facts
- Who runs it
- Universitair Ziekenhuis Brussel
- Where
- Belgium1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 600 people enrolled
- Started
- 6 Jul 2023
- Ended
- 31 Jul 2025
- Type of study
- Observational
- Treatments tested
- Contact the patient
- Record updated
- 12 August 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Positive HCV serology between 2012-2022 with positive or uknown HCV RNA in UZ Brussels database
- ≥18 years
Who cannot take part
- Previously eradicated patients in UZ Brussel
- Positive HCV serology with negative HCV RNA
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Reintroduction of patients into a HCV infection care pathway after a positive chronic hepatitis C diagnosis by previous testing in our hospital who were lost in follow-up.
Read full original descriptionShow less
Gaining insight in the possible reasons why patients are lost in follow-up after positive hepatitis C serology.
The group in the trial
- Diagnosed-but-untreated
Diagnosed but untreated (DBU) HCV patients through positive serology with positive or unknown HCV RNA in UZ Brussel between 2012 - 2022.
Treatment: Contact the patient
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 12 August 2025